Assessing virus like particles formation and r-HBsAg aggregation during large scale production of recombinant hepatitis B surface antigen from Pichia pastoris-Reference-Cited by-同舟云学术

Assessing virus like particles formation and r-HBsAg aggregation during large scale production of recombinant hepatitis B surface antigen from Pichia pastoris

Published:2019-10 Issue: Volume:139 Page:697-711
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Hosseini Seyed Nezamedin,Sarvari Taravat,Bashiri Ghazal,Khatami Maryam,Shojaosadati Seyed Abbas

Funder

Tarbiat Modares University

Pasteur Institute of Iran

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference30 articles.

1. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris

2. Virus-like particles in vaccine development

3. Molecular biology of hepatitis B virus infection

4. Maturation of Recombinant Hepatitis B Virus Surface Antigen Particles

5. Morphogenesis of hepatitis B virus and its subviral envelope particles

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus‐like particles as powerful vaccination strategy against human viruses;Reviews in Medical Virology;2023-12-20

2. A Biological OR(XNOR) Logic Gate Couples Carbon Source and Transgene Expression Switching in a Komagataella phaffii (Pichia pastoris) Strain Co-producing Process-Enhancing Lipase and a Virus- like Particle (VLP) Vaccine;ACS SYNTH BIOL;2023

3. A Biological OR(XNOR) Logic Gate Couples Carbon Source and Transgene Expression Switching in a Komagataella phaffii (Pichia pastoris) Strain Co-producing Process-Enhancing Lipase and a Virus-like Particle (VLP) Vaccine;ACS Synthetic Biology;2023-02-27

4. Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery;Vaccines;2023-02-18

5. Platforms, advances, and technical challenges in virus-like particles-based vaccines;Frontiers in Immunology;2023-02-09